Merck Serono discuss microbial identification at Pharmaceutical Microbiology 2015

LONDON - Oct. 27, 2014 - PRLog -- Pharmaceutical microbiology is of crucial importance to the development and manufacture of pharmaceutical drugs, biologics and devices. Set to take place in January 2015, the event will provide essential insights in to the latest advancements in practice and technology, developments in regulation and harmonisation of international practice and evolving methods.

This event includes a presentation from Merck Serono's Molecular Biology Scientist, Sara Gamberini, entitled: DNA-sequencing based methods - is it really possible to use them for a rapid, efficient and routine based microbial identification in the pharmaceutical industry?

Sara will share in the development of a validated, accurate DNA method to identify bacteria, mycoplasma, fungi and moulds at genus and species level. Attendees will also learn about the improvements that made the method GMP compliant and extensively used for identification of microbial samples coming from biotechnological manufacturing environments and processes.

When asked about her address at the 4th annual conference next January, Sara commented:
"Harmful bacteria and fungi can contaminate raw materials, production facilities and products, therefore identifying these organisms with speed and accuracy can help prevent delayed product releases, back orders, and recalls, with the main purpose of guaranteeing the patient's safety. In this context, correctly identifying contaminating microorganisms is extremely important, in order to put in place effective measures to prevent, control and eliminate them. During Pharmaceutical Microbiology 2015, a presentation describing the steps followed to develop, validate, optimize and automate a genotypic method for rapid identification of bacteria, mycoplasma, fungi and moulds at genus and species level will be provided. There will be the possibility to exchange opinions about this topic and about the challenges related to microorganism identification".

Other key Speakers Include:
• Olivier Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas – CONFERENCE CHAIRMAN
• Ruth Daniels, Head of MSAT, Microbiology, Genzyme
• Hans Noordergraaf, Microbiologist, Abbott Biologicals
• Thomas Schwartz, Microbiology & Molecular Biology Group Leader, Forschungszentrum Karlsrube Gmbh
• Tim Eaton, Sterile Manufacturing, Specialist, AstraZeneca
• Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline
• Phil Duncanson, Director of QC, MedImmune

The event is sponsored by Hyglos GmbH, Steris and Veltek Associates.
For more information go to http://www.smi-online.co.uk/goto/2015pharma-microbiology17.asp

----------END------------

About SMi:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries. More information can be found at http://www.smi-online.co.uk